<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Cancer Treatment Today &#187; Atyoical CML. CML. Chronic Myelogenous Leukemia</title>
	<atom:link href="http://cancertreatmenttoday.org/tag/atyoical-cml-cml-chronic-myelogenous-leukemia/feed/" rel="self" type="application/rss+xml" />
	<link>http://cancertreatmenttoday.org</link>
	<description>Knowledge is Power</description>
	<lastBuildDate>Fri, 24 Apr 2026 13:10:44 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Atypical CML</title>
		<link>http://cancertreatmenttoday.org/atypical-cml/</link>
		<comments>http://cancertreatmenttoday.org/atypical-cml/#comments</comments>
		<pubDate>Fri, 03 Jan 2014 20:38:28 +0000</pubDate>
		<dc:creator>M Levin, MD</dc:creator>
				<category><![CDATA[Chronic Myelogenous Leukemia]]></category>
		<category><![CDATA[Layperson]]></category>
		<category><![CDATA[Atyoical CML. CML. Chronic Myelogenous Leukemia]]></category>

		<guid isPermaLink="false">http://cancertreatmenttoday.org/?p=11779</guid>
		<description><![CDATA[Atypical chronic myelogenous leukemia (aCML) is a leukemic disorder that exhibits both myelodysplastic and myeloproliferative features at the time of diagnosis. What this means is that it is not truly a CML but a condition that can be confused with CML, but is essentially different. It is not very common. It is thought that these [...]]]></description>
			<content:encoded><![CDATA[<p>Atypical chronic myelogenous leukemia (aCML) is a leukemic disorder that exhibits both myelodysplastic and myeloproliferative features at the time of diagnosis. What this means is that it is not truly a CML but a condition that can be confused with CML, but is essentially different. It is not very common. It is thought that these features denote a poor prognosis, but these cases ahve a variety of genetic abnormalities that are different from CML and not much is known about how theya ffect prognosis.  Atypical CML cases are usually BCR-ABL negative. The optimal treatment of aCML is uncertain because of the rare incidence of this chronic leukemic disorder. Treatment with hydroxyurea may lead to short-lived partial remissions of 2- to 4-months&#8217; duration. Atypical CML, appears to respond poorly to treatment with interferon-alpha or other CML treatments.</p>
<p>For Professional version see <a title="Atypical CML – pro" href="http://cancertreatmenttoday.org/atypical-cml-pro/"><span style="color: #ff0000;">here</span></a></p>
]]></content:encoded>
			<wfw:commentRss>http://cancertreatmenttoday.org/atypical-cml/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
